Endovesical treatment as an alternative to BCG for intermediate or high-risk NMI bladder cancer A shortage of BCG is foreseen till the end of 2013. Which will be the management of intermediate and high-risk NMI-BC if BCG will not be available? In patients harboring high-risk NMI tumors, particularly T1G3 and Tis, the first therapeutic choice is radical cystectomy. Device-assisted therapies, although showing promising results, should be considered only for selected patients. In intermediate risk patients, intravesical chemotherapy remains a legitimate option even if BCG is available. Thus, in a period of BCG shortage, intravesical chemotherapy should be offered, preferably preceded by early instillation, according to the EAU guidelines.

Serretta, V., & Colombo, R. (2013). Trattamento endovescicale alternativo al BCG nel carcinoma vescicale NMI a rischio intermedio o elevato. UROLOGIA, 80(80 (S21)), 24-26 [10.5301/RU.2013.10860].

Trattamento endovescicale alternativo al BCG nel carcinoma vescicale NMI a rischio intermedio o elevato

SERRETTA, Vincenzo;
2013

Abstract

Endovesical treatment as an alternative to BCG for intermediate or high-risk NMI bladder cancer A shortage of BCG is foreseen till the end of 2013. Which will be the management of intermediate and high-risk NMI-BC if BCG will not be available? In patients harboring high-risk NMI tumors, particularly T1G3 and Tis, the first therapeutic choice is radical cystectomy. Device-assisted therapies, although showing promising results, should be considered only for selected patients. In intermediate risk patients, intravesical chemotherapy remains a legitimate option even if BCG is available. Thus, in a period of BCG shortage, intravesical chemotherapy should be offered, preferably preceded by early instillation, according to the EAU guidelines.
Settore MED/24 - Urologia
Serretta, V., & Colombo, R. (2013). Trattamento endovescicale alternativo al BCG nel carcinoma vescicale NMI a rischio intermedio o elevato. UROLOGIA, 80(80 (S21)), 24-26 [10.5301/RU.2013.10860].
File in questo prodotto:
File Dimensione Formato  
Urologia_OQ_2013_26-29.pdf

non disponibili

Descrizione: articolo
Dimensione 164.51 kB
Formato Adobe PDF
164.51 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10447/82505
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact